Found: 20
Select item for more details and to access through your institution.
FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00495-3
- By:
- Publication type:
- Article
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00494-4
- By:
- Publication type:
- Article
Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00493-5
- By:
- Publication type:
- Article
Real-world renal function among patients with multiple myeloma in the United States.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00490-8
- By:
- Publication type:
- Article
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00488-2
- By:
- Publication type:
- Article
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00487-3
- By:
- Publication type:
- Article
Comprehensive Review of AL amyloidosis: some practical recommendations.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00486-4
- By:
- Publication type:
- Article
Conditional relative survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma in the Netherlands.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5
- By:
- Publication type:
- Article
Author Correction: Mutational landscape and its clinical significance in paroxysmal nocturnal hemoglobinuria.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00483-7
- By:
- Publication type:
- Article
SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00484-6
- By:
- Publication type:
- Article
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00480-w
- By:
- Publication type:
- Article
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00479-3
- By:
- Publication type:
- Article